midazolam has been researched along with netupitant in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lanzarotti, C; Rossi, G | 1 |
1 trial(s) available for midazolam and netupitant
Article | Year |
---|---|
Effect of netupitant, a highly selective NK₁ receptor antagonist, on the pharmacokinetics of midazolam, erythromycin, and dexamethasone.
Topics: Adult; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dexamethasone; Drug Administration Schedule; Drug Interactions; Erythromycin; Humans; Male; Midazolam; Middle Aged; Neurokinin-1 Receptor Antagonists; Pyridines; Young Adult | 2013 |